Inventor · disambiguated record
Harold Mastalerz
Also filed as: MASTALERZ HAROLD · MASTALERZ HAROLD A
24 granted patents·6 pending applications·288 citations·filing 1997–2018
96Inventor score
Files withBRISTOL MYERS SQUIBB CO25MASTALERZ HAROLD2KADOW JOHN F1PURANDARE ASHOK VINAYAK1WITTMAN MARK D1
Top patents by PatentIndex Score
30 records- 0194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0294US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 0394US6916815B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 12, 2005·55 cites·10 claims
- 0490US7148220B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 12, 2006·13 cites·3 claims
- 0589US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 0689US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 0789US6908916B2C-5 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 21, 2005·34 cites·9 claims
- 0888US7232901B2Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediatesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 19, 2007·10 cites·18 claims
- 0985US7102003B2Pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 5, 2006·11 cites·5 claims
- 1084US7442700B2Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 28, 2008·5 cites·20 claims
- 1184US6750246B1C-4 carbonate taxanesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jun 15, 2004·29 cites·13 claims
- 1283US8815840B2Carbazole and carboline kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted Aug 26, 2014·5 cites·6 claims
- 1381US7619083B2Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediatesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 17, 2009·4 cites·18 claims
- 1479US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1579US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1678US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 1777US7064203B2Di-substituted pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jun 20, 2006·9 cites·6 claims
- 1876US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 1973US11166959B2Isofuranone compounds useful as HPK1 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 9, 2021·1 cites·15 claims
- 2072US6916942B2Process for the preparation of C-4 carbonate taxanesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 12, 2005·4 cites·30 claims
- 2164US6017935A7-sulfur substituted paclitaxelsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Jan 25, 2000·10 cites·19 claims
- 2263US2009062288A1Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithMASTALERZ HAROLD·Filed 2008·Application pending·0 cites
- 2356US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 2454US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2553US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2650US5977386A6-thio-substituted paclitaxelsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Nov 2, 1999·5 cites·10 claims
- 2749US2005209235A1C-5 Modified indazolylpyrrolotriazinesMASTALERZ HAROLD·Filed 2005·Application pending·0 cites
- 2848US2010137319A1Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2948US2005250844A1Methods of treating cancer using C-4 carbonate taxanesKADOW JOHN F·Filed 2005·Application pending·0 cites
- 3036US10301306B2Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 28, 2019·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →